HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,3-bisbenzylimidazolium

has antioxidant activity; structure in first source

Also Known As:

1,3-bisbenzylimidazolium bromide; DBZIM cpd

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - 1,3-bisbenzylimidazolium: 2

Experts

1.	Kumar, Saravana: 2 articles (01/2018 - 06/2011)
2.	Zhuo, Lang: 2 articles (01/2018 - 06/2011)
3.	Chan, Hugh H: 1 article (01/2018)
4.	Tse, Man Kit: 1 article (01/2018)
5.	Chan, Hugh Hiu Nam: 1 article (06/2011)
6.	Ho, Gideon: 1 article (06/2011)
7.	Ke, Zhiyuan: 1 article (06/2011)
8.	Kng, Yin Ling: 1 article (06/2011)
9.	Suhaimi, Nur-Afidah Mohamed: 1 article (06/2011)
10.	Zhang, Yugen: 1 article (06/2011)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/05/2018 - "We previously reported that 1,3-bisbenzylimidazolium (DBZIM) bromide was neuroprotective for the dopaminergic system in Parkinson's disease (PD) models of rodent, however the underlying mechanism was unclear. "
2.	Gliosis 06/01/2011 - "Here, we investigate one of the IMSs, 1,3-bisbenzylimidazolium bromide (DBZIM), for its possible role in attenuating neurotoxicity and gliosis in the retina and the brain induced by a Parkinsonian neurtoxicant, methyl-4(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH(3) -MPTP), which is a free radical generating agent. "

Related Drugs and Biologics

1.	Free Radicals
2.	Bromides